Article
Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.
Journal of clinical pharmacology - 1 Apr 2008
Kharasch Evan D, Mitchell Darain, Coles Rebecka
Abstract excerpt
The clearance of racemic bupropion, metabolized selectively by CYP2B6 in vitro, has been used clinically to phenotype CYP2B6 activity, polymorphisms, and drug interactions but has known limitations. Bupropion hydroxylation by CYP2B6 is stereoselective. This investigation assessed the stereoselect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
